Literature DB >> 10585306

Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications.

S Bianchi1, R Bigazzi, V M Campese.   

Abstract

Some patients with essential hypertension manifest greater than normal urinary albumin excretion (UAE). The significance of this association, which is the object of this review, is not well established. Hypertensive patients with microalbuminuria manifest greater levels of blood pressure, particularly at night, and higher serum levels of cholesterol, triglycerides, and uric acid than patients with normal UAE. Levels of high-density lipoprotein cholesterol, on the other hand, were lower in patients with microalbuminuria than in those with normal UAE. Patients with microalbuminuria manifested greater incidence of insulin resistance and thicker carotid arteries than patients with normal UAE. After a follow-up of 7 years, we observed that 12 cardiovascular events occurred among 54 (21.3%) patients with microalbuminuria and only two such events among 87 patients with normal UAE (P < 0.0002). Stepwise logistic regression analysis showed that UAE, cholesterol level, and diastolic blood pressure were independent predictors of the cardiovascular outcome. Rate of creatinine clearance from patients with microalbuminuria decreased more than that from those with normal UAE. In conclusion, these studies suggest that hypertensive individuals with microalbuminuria manifest a variety of biochemical and hormonal derangements with pathogenic potential, which results in hypertensive patients having a greater incidence of cardiovascular events and a greater decline in renal function than patients with normal UAE.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585306     DOI: 10.1016/S0272-6386(99)70002-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  29 in total

Review 1.  Why beta-blockers are not cardioprotective in elderly patients with hypertension.

Authors:  Ehud Grossman; Franz H Messerli
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

2.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

Review 3.  Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.

Authors:  Christine R Culy; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Moderately increased albuminuria unmasked hypertension.

Authors:  Salvador Pertusa; Carlos Ramos-Lopez; Martha Martinez-Navas; Ana Palacios-Marqués
Journal:  BMJ Case Rep       Date:  2014-10-30

5.  Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.

Authors:  Adam Whaley-Connell; Ravi Nistala; Javad Habibi; Melvin R Hayden; Rebecca I Schneider; Megan S Johnson; Roger Tilmon; Nathan Rehmer; Carlos M Ferrario; James R Sowers
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-09

6.  Urinary glycosaminoglycans in the course of familial Mediterranean fever.

Authors:  Esra Baskin; Umit Saatçi; Gönenç Ciliv; Aysin Bakkaloglu; Nesrin Besbas; Rezan Topaloglu; Seza Ozen
Journal:  Eur J Pediatr       Date:  2003-03-04       Impact factor: 3.183

7.  Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men>40 years of age (from the Rancho Bernardo Study).

Authors:  Simerjot Kaur Jassal; Claudia Langenberg; Denise von Mühlen; Jaclyn Bergstrom; Elizabeth Barrett-Connor
Journal:  Am J Cardiol       Date:  2008-03-07       Impact factor: 2.778

Review 8.  Is proteinuria a plausible target of therapy?

Authors:  Dave C Y Chua; George L Bakris
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

9.  Cumulative systolic BP and changes in urine albumin-to-creatinine ratios in nondiabetic participants of the multi-ethnic study of atherosclerosis.

Authors:  Paul Zemaitis; Kiang Liu; David R Jacobs; Mary Cushman; Ramon Durazo-Arvizu; David Shoham; Walter Palmas; Richard Cooper; Holly Kramer
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-08       Impact factor: 8.237

Review 10.  Prehypertension: epidemiology, consequences and treatment.

Authors:  Eduardo Pimenta; Suzanne Oparil
Journal:  Nat Rev Nephrol       Date:  2009-11-17       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.